COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?

BACKGROUND: Coronavirus disease 19 (COVID-19) is a novel disease entity that is spreading throughout the world. It has been speculated that patients with comorbidities and elderly patients could be at high risk for respiratory insufficiency and death. Immunosuppression could expose infected patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mult Scler Relat Disord
Main Authors: Novi, Giovanni, Mikulska, Malgorzata, Briano, Federica, Toscanini, Federica, Tazza, Francesco, Uccelli, Antonio, Inglese, Matilde
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier B.V. 2020
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7156942/
https://ncbi.nlm.nih.gov/pubmed/32315980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2020.102120
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados